The therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice (Q40073701)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice |
scientific article |
Statements
1 reference
The therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice (English)
1 reference
Qi Li
1 reference
Seiji Yano
1 reference
Hirokazu Ogino
1 reference
Wei Wang
1 reference
Hisanori Uehara
1 reference
Yasuhiko Nishioka
1 reference
Saburo Sone
1 reference
1 October 2007
1 reference
1 reference
Identifiers
1 reference